Niramai

NiramaiNiramai
Niramai

Niramai

AI-powered, radiation-free breast cancer screening using thermal imaging.

DR 59Speed 482016ActiveBengaluru, India
Rate

About

Niramai Health Analytix develops an AI-based medical device called Thermalytix for early breast cancer detection. This non-invasive, radiation-free solution uses thermal imaging and machine learning to analyze temperature patterns, offering an affordable and accessible screening method for women of all ages. The company aims to improve breast cancer mortality rates through early diagnosis and has received regulatory clearances from the US FDA and European CE Mark.
Frequently asked

What does Niramai do?

Niramai Health Analytix develops an AI-based medical device called Thermalytix for early breast cancer detection. This non-invasive, radiation-free solution uses thermal imaging and machine learning to analyze temperature patterns, offering an affordable and accessible screening method for women of all ages. The company aims to improve breast cancer mortality rates through early diagnosis and has received regulatory clearances from the US FDA and European CE Mark.

What is Niramai's revenue?

StartupHub estimates Niramai's annual revenue at $23.9M (range $8.5M to $87.9M, 33% confidence), based on comparable companies in the sector.

What is Niramai's valuation?

StartupHub estimates Niramai's effective valuation at $480.5M (range $297.5M to $714.0M, 20% confidence), based on comparable companies in the sector.

How much funding has Niramai raised?

Niramai has raised a total of $119M in funding. The most recent round on record is Series B.

Where is Niramai headquartered?

Niramai is headquartered in Bengaluru, India.

When was Niramai founded?

Niramai was founded in 2016.

What industry does Niramai operate in?

Niramai operates in HealthTech, MedTech, AI-driven Drug Discovery, Medical Imaging, FemTech, Oncology.

Comments

No comments yet. Be the first to share your take.